Multimedialna platforma wiedzy medycznej Internetowa Księgarnia Medyczna Kalendarium Konferencji
Endokrynologia Polska
MENU
Shortcuts Submit an article Author Guidelines Polish Society of Endocrinology Reviewers 2023 Redeem voucher

open access

Vol 75, No 1 (2024)
Original paper
Submitted: 2023-07-11
Accepted: 2023-09-14
Published online: 2023-11-09
View PDF Download PDF file View HTML
Get Citation

Association between sleep duration and metabolic syndrome: a population-based study in China

Ziyi Sun1, Xi Yang2, Ling Bai3, Ridong Huang4, Zuojie Luo1, Li Li1, Yingfen Qin1, Jia Zhou1, Liheng Meng1, Yang Peng5, Xinghuan Liang1
DOI: 10.5603/ep.96448
·
Pubmed: 38497390
·
Endokrynol Pol 2024;75(1):51-60.
Affiliations
  1. Department of Endocrinology, The First Affiliated Hospital of Guangxi Medical University, Guangxi Endocrine Clinical Key Specialty, Nanning, China
  2. Department of Geriatric Endocrinology and Metabolism & Guangxi Key Laboratory of Precision Medicine in Cardio-Cerebrovascular Diseases Control and Prevention & Guangxi Clinical Research Centre for Cardio-Cerebrovascular Diseases, The First Affiliated Hospital of Guangxi Medical University, Nanning, China
  3. Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China
  4. Department of Bone and Joint Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China
  5. Department of Occupational and Environmental Health, School of Public Health, Guangxi Medical University, Nanning, China

open access

Vol 75, No 1 (2024)
Original Paper
Submitted: 2023-07-11
Accepted: 2023-09-14
Published online: 2023-11-09

Abstract

Introduction: The relationship between sleep duration and metabolic syndrome (MetS) remains debatable. In the present study, we analysed the link between total sleep duration (including nighttime sleep and nap duration) and MetS as well as its components among the Chinese population.

Material and methods: This was a cross-sectional study from a prospective population cohort including 8616 participants over 40 years in Guangxi, China, evaluated from April 2011 to January 2012. MetS was diagnosed using modified criteria from the National Cholesterol Education Program’s Adult Treatment Panel III. Sleep information was obtained through a standard self-report-based questionnaire. The connection between sleep duration and MetS prevalence as well as its components was evaluated using a logistic regression model.

Results: After adjusting for potential confoundings, the longer daily sleep duration (≥ 10 hours) group was observed to have the higher odds of having MetS than the reference group with ≥ 7 and < 8 hours of sleep [odds ratio (OR): 1.25, 95% confidence interval (CI): 1.03–1.52, p = 0.023], as well as the highest odds of having elevated triglycerides (OR: 1.25, 95% CI: 1.03–1.52) and fasting blood glucose (OR: 1.21, 95% CI: 1.01–1.45). Further analysis demonstrated that sleeping > 9 hours per night was correlated to MetS in females (OR: 1.27, 95% CI: 1.02–1.58), while napping ≥ 90 minutes was correlated to MetS (OR: 1.44, 95% CI: 1.11–1.87) in males.

Conclusion: Both longer nighttime sleep duration and longer naps may be associated with the development of MetS.

Abstract

Introduction: The relationship between sleep duration and metabolic syndrome (MetS) remains debatable. In the present study, we analysed the link between total sleep duration (including nighttime sleep and nap duration) and MetS as well as its components among the Chinese population.

Material and methods: This was a cross-sectional study from a prospective population cohort including 8616 participants over 40 years in Guangxi, China, evaluated from April 2011 to January 2012. MetS was diagnosed using modified criteria from the National Cholesterol Education Program’s Adult Treatment Panel III. Sleep information was obtained through a standard self-report-based questionnaire. The connection between sleep duration and MetS prevalence as well as its components was evaluated using a logistic regression model.

Results: After adjusting for potential confoundings, the longer daily sleep duration (≥ 10 hours) group was observed to have the higher odds of having MetS than the reference group with ≥ 7 and < 8 hours of sleep [odds ratio (OR): 1.25, 95% confidence interval (CI): 1.03–1.52, p = 0.023], as well as the highest odds of having elevated triglycerides (OR: 1.25, 95% CI: 1.03–1.52) and fasting blood glucose (OR: 1.21, 95% CI: 1.01–1.45). Further analysis demonstrated that sleeping > 9 hours per night was correlated to MetS in females (OR: 1.27, 95% CI: 1.02–1.58), while napping ≥ 90 minutes was correlated to MetS (OR: 1.44, 95% CI: 1.11–1.87) in males.

Conclusion: Both longer nighttime sleep duration and longer naps may be associated with the development of MetS.

Full Text:

View PDF Download PDF file View HTML
Get Citation

Keywords

sleep duration; daily nap; MetS

About this article
Title

Association between sleep duration and metabolic syndrome: a population-based study in China

Journal

Endokrynologia Polska

Issue

Vol 75, No 1 (2024)

Article type

Original paper

Pages

51-60

Published online

2023-11-09

Page views

345

Article views/downloads

290

DOI

10.5603/ep.96448

Pubmed

38497390

Bibliographic record

Endokrynol Pol 2024;75(1):51-60.

Keywords

sleep duration
daily nap
MetS

Authors

Ziyi Sun
Xi Yang
Ling Bai
Ridong Huang
Zuojie Luo
Li Li
Yingfen Qin
Jia Zhou
Liheng Meng
Yang Peng
Xinghuan Liang

References (43)
  1. Nilsson PM, Tuomilehto J, Rydén L. The metabolic syndrome - What is it and how should it be managed? Eur J Prev Cardiol. 2019; 26(2_suppl): 33–46.
    CrossRefPubMed
  2. Engin A. The Definition and Prevalence of Obesity and Metabolic Syndrome. Adv Exp Med Biol. 2017; 960: 1–17.
    CrossRefPubMed
  3. Saklayen MG. The Global Epidemic of the Metabolic Syndrome. Curr Hypertens Rep. 2018; 20(2): 12.
    CrossRefPubMed
  4. Alberti KG, Eckel RH, Grundy SM, et al. International Diabetes Federation Task Force on Epidemiology and Prevention, Hational Heart, Lung, and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society, International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009; 120(16): 1640–1645.
    CrossRefPubMed
  5. Li Ri, Li W, Lun Z, et al. Prevalence of metabolic syndrome in Mainland China: a meta-analysis of published studies. BMC Public Health. 2016; 16: 296.
    CrossRefPubMed
  6. McDevitt EA, Sattari N, Duggan KA, et al. The impact of frequent napping and nap practice on sleep-dependent memory in humans. Sci Rep. 2018; 8(1): 15053.
    CrossRefPubMed
  7. Lin CL, Lin CP, Chen SW, et al. The association between sleep duration and overweight or obesity in Taiwanese adults: A cross-sectional study. Obes Res Clin Pract. 2018; 12(4): 384–388.
    CrossRefPubMed
  8. Reutrakul S, Van Cauter E. Sleep influences on obesity, insulin resistance, and risk of type 2 diabetes. Metabolism. 2018; 84: 56–66.
    CrossRefPubMed
  9. Lin Pu, Chang KT, Lin YA, et al. Association between self-reported sleep duration and serum lipid profile in a middle-aged and elderly population in Taiwan: a community-based, cross-sectional study. BMJ Open. 2017; 7(10): e015964.
    CrossRefPubMed
  10. van Namen M, Prendergast L, Peiris C. Supervised lifestyle intervention for people with metabolic syndrome improves outcomes and reduces individual risk factors of metabolic syndrome: A systematic review and meta-analysis. Metabolism. 2019; 101: 153988.
    CrossRefPubMed
  11. Ohkuma T, Fujii H, Iwase M, et al. U-shaped association of sleep duration with metabolic syndrome and insulin resistance in patients with type 2 diabetes: the Fukuoka Diabetes Registry. Metabolism. 2014; 63(4): 484–491.
    CrossRefPubMed
  12. Xie J, Li Y, Zhang Y, et al. Sleep duration and metabolic syndrome: An updated systematic review and meta-analysis. Sleep Med Rev. 2021; 59: 101451.
    CrossRefPubMed
  13. Wu J, Xu G, Shen L, et al. Daily sleep duration and risk of metabolic syndrome among middle-aged and older Chinese adults: cross-sectional evidence from the Dongfeng-Tongji cohort study. BMC Public Health. 2015; 15: 178.
    CrossRefPubMed
  14. Fang W, Li Z, Wu Li, et al. Longer habitual afternoon napping is associated with a higher risk for impaired fasting plasma glucose and diabetes mellitus in older adults: results from the Dongfeng-Tongji cohort of retired workers. Sleep Med. 2013; 14(10): 950–954.
    CrossRefPubMed
  15. Mantua J, Spencer RMC. Exploring the nap paradox: are mid-day sleep bouts a friend or foe? Sleep Med. 2017; 37: 88–97.
    CrossRefPubMed
  16. Leng Y, Redline S, Stone KL, et al. Objective napping, cognitive decline, and risk of cognitive impairment in older men. Alzheimers Dement. 2019; 15(8): 1039–1047.
    CrossRefPubMed
  17. Wang N, Zou J, Fang S, et al. Association between daytime napping and obesity in Chinese middle-aged and older adults. J Glob Health. 2020; 10(2): 020804.
    CrossRefPubMed
  18. Yamada T, Shojima N, Yamauchi T, et al. J-curve relation between daytime nap duration and type 2 diabetes or metabolic syndrome: A dose-response meta-analysis. Sci Rep. 2016; 6: 38075.
    CrossRefPubMed
  19. Léger D, Torres MJ, Bayon V, et al. The association between physical and mental chronic conditions and napping. Sci Rep. 2019; 9(1): 1795.
    CrossRefPubMed
  20. van der Pal KC, Koopman ADM, Lakerveld J, et al. The association between multiple sleep-related characteristics and the metabolic syndrome in the general population: the New Hoorn study. Sleep Med. 2018; 52: 51–57.
    CrossRefPubMed
  21. He J, Ouyang F, Qiu D, et al. Association of Nap Duration after Lunch with Prevalence of Metabolic Syndrome in a Chinese Government Employee Population. Int J Environ Res Public Health. 2020; 17(12).
    CrossRefPubMed
  22. Ning G. Reaction Study Group. Risk Evaluation of cAncers in Chinese diabeTic Individuals: a lONgitudinal (REACTION) study. J Diabetes. 2012; 4(2): 172–173.
    CrossRefPubMed
  23. Bi Y, Lu J, Wang W, et al. Cohort profile: risk evaluation of cancers in Chinese diabetic individuals: a longitudinal (REACTION) study. J Diabetes. 2014; 6(2): 147–157.
    CrossRefPubMed
  24. Peng K, Chen G, Liu C, et al. REACTION Study Group, REACTION Study Group. Glycemic status and chronic kidney disease in Chinese adults: Findings from the REACTION study. J Diabetes. 2017; 9(9): 837–845.
    CrossRefPubMed
  25. Moriarty DG, Zack MM, Kobau R. The Centers for Disease Control and Prevention's Healthy Days Measures - population tracking of perceived physical and mental health over time. Health Qual Life Outcomes. 2003; 1: 37.
    CrossRefPubMed
  26. Wang L, Gao P, Zhang M, et al. Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013. JAMA. 2017; 317(24): 2515–2523.
    CrossRefPubMed
  27. Grundy SM, Cleeman JI, Daniels SR, et al. American Heart Association, National Heart, Lung, and Blood Institue. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. Cardiol Rev. 2005; 13(6): 322–327.
    PubMed
  28. Yang L, Xu Z, He M, et al. Sleep Duration and Midday Napping with 5-Year Incidence and Reversion of Metabolic Syndrome in Middle-Aged and Older Chinese. Sleep. 2016; 39(11): 1911–1918.
    CrossRefPubMed
  29. Iftikhar IH, Donley MA, Mindel J, et al. Sleep Duration and Metabolic Syndrome. An Updated Dose-Risk Metaanalysis. Ann Am Thorac Soc. 2015; 12(9): 1364–1372.
    CrossRefPubMed
  30. Smiley A, King D, Bidulescu A. The Association between Sleep Duration and Metabolic Syndrome: The NHANES 2013/2014. Nutrients. 2019; 11(11).
    CrossRefPubMed
  31. Harlow SD, Gass M, Hall JE, et al. STRAW + 10 Collaborative Group, STRAW 10 Collaborative Group, STRAW + 10 Collaborative Group, STRAW+10 Collaborative Group. Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive aging. Climacteric. 2012; 15(2): 105–114.
    CrossRefPubMed
  32. Baker FC, Willoughby AR, Sassoon SA, et al. Insomnia in women approaching menopause: Beyond perception. Psychoneuroendocrinology. 2015; 60: 96–104.
    CrossRefPubMed
  33. Polo-Kantola P. Sleep problems in midlife and beyond. Maturitas. 2011; 68(3): 224–232.
    CrossRefPubMed
  34. de Zambotti M, Colrain IM, Baker FC. Interaction between reproductive hormones and physiological sleep in women. J Clin Endocrinol Metab. 2015; 100(4): 1426–1433.
    CrossRefPubMed
  35. Joffe H, Crawford S, Economou N, et al. A gonadotropin-releasing hormone agonist model demonstrates that nocturnal hot flashes interrupt objective sleep. Sleep. 2013; 36(12): 1977–1985.
    CrossRefPubMed
  36. Irwin MR, Olmstead R, Carroll JE. Sleep Disturbance, Sleep Duration, and Inflammation: A Systematic Review and Meta-Analysis of Cohort Studies and Experimental Sleep Deprivation. Biol Psychiatry. 2016; 80(1): 40–52.
    CrossRefPubMed
  37. Kanmani S, Kwon M, Shin MK, et al. Association of C-Reactive Protein with Risk of Developing Type 2 Diabetes Mellitus, and Role of Obesity and Hypertension: A Large Population-Based Korean Cohort Study. Sci Rep. 2019; 9(1): 4573.
    CrossRefPubMed
  38. Pan Z, Huang M, Huang J, et al. Association of napping and all-cause mortality and incident cardiovascular diseases: a dose-response meta analysis of cohort studies. Sleep Med. 2020; 74: 165–172.
    CrossRefPubMed
  39. Smolensky MH, Hermida RC, Castriotta RJ, et al. Role of sleep-wake cycle on blood pressure circadian rhythms and hypertension. Sleep Med. 2007; 8(6): 668–680.
    CrossRefPubMed
  40. Borel AL. Sleep Apnea and Sleep Habits: Relationships with Metabolic Syndrome. Nutrients. 2019; 11(11).
    CrossRefPubMed
  41. Zhang Z, Cajochen C, Khatami R. Social Jetlag and Chronotypes in the Chinese Population: Analysis of Data Recorded by Wearable Devices. J Med Internet Res. 2019; 21(6): e13482.
    CrossRefPubMed
  42. Yadav D, Lee MiY, Kim JY, et al. A prospective study of serum adiponectin and regression of metabolic syndrome: The ARIRANG study. Biochem Biophys Res Commun. 2015; 466(2): 201–205.
    CrossRefPubMed
  43. Okamoto Y, Kihara S, Funahashi T, et al. Adiponectin: a key adipocytokine in metabolic syndrome. Clin Sci (Lond). 2006; 110(3): 267–278.
    CrossRefPubMed

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą jest  VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl